HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter Kuhn Selected Research
Peter Kuhn Research Topics
Disease
53
Neoplasms (Cancer)
02/2024 - 02/2006
17
Circulating Neoplastic Cells
01/2024 - 02/2012
16
Prostatic Neoplasms (Prostate Cancer)
08/2023 - 07/2008
9
Breast Neoplasms (Breast Cancer)
08/2023 - 01/2012
7
Retinoblastoma (Glioblastoma, Retinal)
05/2023 - 11/2018
6
Lung Neoplasms (Lung Cancer)
01/2019 - 01/2012
6
Body Weight (Weight, Body)
08/2018 - 03/2009
4
Disease Progression
12/2023 - 03/2018
4
Neoplasm Metastasis (Metastasis)
06/2022 - 11/2010
4
Carcinogenesis
06/2022 - 09/2006
4
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 07/2014
4
Infections
11/2010 - 06/2007
3
Hepatocellular Carcinoma (Hepatoma)
12/2020 - 12/2012
3
Necrosis
12/2019 - 03/2012
3
Inflammation (Inflammations)
01/2018 - 04/2010
3
Weight Gain
08/2015 - 02/2013
3
Insulin Resistance
06/2015 - 01/2014
3
Hyperglycemia
01/2014 - 05/2009
3
Severe Acute Respiratory Syndrome
02/2009 - 04/2008
2
Hematologic Neoplasms (Hematological Malignancy)
02/2024 - 11/2022
2
Multiple Myeloma
10/2023 - 09/2023
2
Urinary Bladder Neoplasms (Bladder Cancer)
02/2022 - 01/2019
2
Adenocarcinoma
01/2016 - 07/2008
2
Thrombosis (Thrombus)
01/2016 - 02/2015
2
Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 02/2012
2
Obesity
08/2015 - 06/2015
2
Fatty Liver
06/2015 - 07/2014
2
Type 2 Diabetes Mellitus (MODY)
12/2012 - 03/2009
2
Stress Urinary Incontinence
06/2011 - 11/2006
2
Urinary Incontinence
01/2009 - 11/2006
1
COVID-19
04/2023
1
Plasma Cell Neoplasms
11/2022
1
Uveal melanoma
06/2022
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1
Monoclonal Gammopathy of Undetermined Significance
01/2022
1
Hodgkin Disease (Hodgkin's Disease)
01/2022
1
Retinal Detachment (Retinal Detachments)
07/2021
1
Chromosomal Instability (Chromosome Stability)
07/2021
1
Genomic Instability
01/2020
Drug/Important Bio-Agent (IBA)
19
Biomarkers (Surrogate Marker)
IBA
12/2023 - 01/2013
16
Proteins (Proteins, Gene)
FDA Link
12/2023 - 09/2006
12
Cell-Free Nucleic Acids
IBA
11/2023 - 11/2017
10
DNA (Deoxyribonucleic Acid)
IBA
12/2022 - 09/2009
7
Glucose (Dextrose)
FDA Link
Generic
08/2018 - 12/2012
6
Keratins (Keratin)
IBA
01/2024 - 02/2012
5
Polyphenols
IBA
01/2018 - 02/2013
4
DAPI
IBA
01/2024 - 08/2014
4
TFX
IBA
11/2023 - 01/2020
4
Nucleotides
IBA
11/2023 - 12/2020
4
Insulin (Novolin)
FDA Link
11/2016 - 12/2012
4
Ligands
IBA
01/2015 - 02/2006
3
Epithelial Cell Adhesion Molecule
IBA
08/2023 - 01/2013
3
Hormones (Hormone)
IBA
01/2022 - 01/2017
3
Tumor Biomarkers (Tumor Markers)
IBA
03/2021 - 08/2014
3
Androgen Receptors (Androgen Receptor)
IBA
12/2020 - 02/2012
3
Ephrins
IBA
01/2015 - 02/2006
3
Hypoglycemic Agents (Hypoglycemics)
IBA
07/2014 - 03/2009
2
Proteome
IBA
09/2023 - 04/2008
2
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 09/2017
2
Acetates (Acetic Acid Esters)
FDA Link
01/2019 - 01/2017
2
Lipopolysaccharides
IBA
11/2016 - 08/2015
2
Lipids
IBA
11/2016 - 07/2014
2
Thromboplastin (Tissue Factor)
IBA
01/2016 - 02/2015
2
Eph Family Receptors (Eph Receptors)
IBA
01/2015 - 12/2007
2
Cholesterol
IBA
02/2013 - 04/2003
2
Phosphotransferases (Kinase)
IBA
12/2007 - 02/2006
1
brexucabtagene autoleucel
IBA
02/2024
1
Chimeric Antigen Receptors
IBA
02/2024
1
axicabtagene ciloleucel
IBA
02/2024
1
Vimentin
IBA
01/2024
1
Immunologic Factors (Immunomodulators)
IBA
12/2023
1
Bortezomib (Velcade)
FDA Link
10/2023
1
Dexamethasone (Maxidex)
FDA Link
Generic
10/2023
1
Ambar
IBA
10/2023
1
Calcibiotic Root Canal Sealer
IBA
08/2023
1
diazonaphthalenedisulfonic acid (NDS)
IBA
04/2023
1
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
11/2022
1
B-Cell Maturation Antigen
IBA
11/2022
1
neratinib
IBA
02/2022
1
Everolimus
FDA Link
01/2022
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
Anastrozole (Arimidex)
FDA Link
Generic
01/2022
1
Fulvestrant (Faslodex)
FDA Link
01/2022
1
Circulating Tumor DNA
IBA
01/2022
1
cabazitaxel
FDA Link
12/2021
1
Carboplatin (JM8)
FDA Link
Generic
12/2021
1
Cyclin-Dependent Kinase 4
IBA
01/2021
1
enzalutamide
IBA
12/2020
1
Sorafenib (BAY 43-9006)
FDA Link
12/2020
1
Paraffin
IBA
01/2020
Therapy/Procedure
21
Therapeutics
11/2023 - 09/2006
7
Drug Therapy (Chemotherapy)
01/2022 - 01/2014
4
Castration
12/2021 - 01/2017
2
Cystectomy
02/2022 - 01/2019
2
Oral Administration
01/2014 - 04/2010
1
Operative Surgical Procedures
02/2024
1
Immunomodulation
12/2023
1
Oncolytic Virotherapy
10/2023
1
Aftercare (After-Treatment)
01/2020
1
Fitness Trackers
01/2020